Home Medix HM-KX 10 LPM vs Nidek Nuvo 10 LPM

The Home Medix HM-KX 10 LPM and the Nidek Nuvo 10 LPM are the closest head-to-head in the Indian 10 LPM class. Both target the full high-flow clinical range. Both carry current regulatory paperwork — Nidek with FDA + CE, HM-KX with CDSCO + ISO 9001 + ISO 13485. The split is sharpest on price (HM-KX roughly half of a typical Nuvo 10 street price), feature density (integrated nebulization and the SOS siren are HM-KX-only), and on ecosystem factors — clinical trust, resale retention, and urban service reach all favour Nuvo. This is the 10 LPM comparison where honest context matters; neither unit is a clear knockout.

At a glance

• Price. HM-KX indicative retail roughly ₹65,000 in 2026 (listed MRP ₹85,000). Nidek Nuvo 10 indicative retail roughly ₹1,25,000–₹1,45,000 across authorised-dealer channels; a low-end scraped listing of ~₹94,000 sits at the bottom of that band. HM-KX is meaningfully cheaper at either end.
• Weight. Nuvo 10 published at 29.26 kg on the local datasheet; HM-KX at 25.6 kg — so on the like-for-like 10 LPM published spec, HM-KX is ~3.7 kg lighter. The broader Nuvo line (Nuvo Lite 5, Nuvo 8) ships in meaningfully lighter variants for buyers who do not need the full 10 L/min ceiling.
• Flow range. HM-KX 0.5–10 L/min vs Nuvo 10 2–10 L/min — HM-KX covers the sub-2 L/min titration band Nuvo 10 does not.
• Oxygen purity. HM-KX 93% ± 3% (90–96%) vs Nuvo 10 87–95%.
• Sound level (published). HM-KX ≤ 48 dB(A) field-verified vs Nuvo 10 58 dB on the local datasheet. HM-KX ~10 dB quieter on published specs — a near-halving of perceived loudness. (Nidek’s broader Nuvo reputation is frequently cited at ≤ 48 dB; anchoring to that figure makes it a tie.)
• Power consumption. HM-KX 550 VA vs Nuvo 10 600 W — HM-KX ~8% lower and the lowest in the 10 LPM class.
• Outlet pressure. HM-KX 0.04–0.06 MPa (~5.8–8.7 psi) vs Nuvo 10 15 psi.
• Warranty. HM-KX 3 years or 10,000 hours, whichever first. Nuvo 10 typically 1 year on the Indian channel.
• Regulatory. HM-KX ISO 9001 + ISO 13485 + CDSCO. Nuvo 10 US FDA + CE.

Where the HM-KX wins

Price. HM-KX at roughly ₹65,000 against a typical Nuvo 10 street band of ₹1,25,000–₹1,45,000 is a ~₹60,000–₹80,000 saving. Even against the lowest-end scraped Nuvo pricing near ₹94,000, HM-KX is ~₹29,000 cheaper. The saving funds a bridge-rental during downtime, a second 5 LPM unit, or a full year of consumables.

Warranty terms. HM-KX’s 3 years or 10,000 hours clause exceeds the typical 1-year Indian-channel Nuvo warranty on paper. A chronic LTOT patient running 20 hours a day hits 10,000 hours in ~17 months, so calendar and hour clauses interact — but the stated HM-KX window is longer.

Integrated nebulization. HM-KX can deliver oxygen-entrained nebulized medication through the same circuit. Not on Nuvo 10’s published spec — the Nuvo setup typically requires a separate compressor nebulizer for patients on concurrent bronchodilator or steroid nebulization.

One-touch SOS alert. HM-KX ships with a factory-integrated high-volume audible SOS button. The alarm is a hardwired local distress siren audible across a typical Indian home — no mobile app, no SMS, no IoT telemetry, and therefore no tower or data-pack dependency to fail. Validated across 100+ dealer deployments. Useful for bedridden or voice-weak patients whose call would not otherwise carry. Nuvo 10 has no equivalent.

Power draw. HM-KX at 550 VA against the Nuvo 10’s 600 W is ~8% lower. At ₹8/kWh, 24/7 operation is roughly ₹3,200/month for HM-KX vs ~₹3,500/month for the Nuvo 10 — ~₹300/month spread, ~₹10,800 across three years. Real but not primary.

Alarms, AC tolerance, hour counter. HM-KX publishes a full four-alarm suite (Low Oxygen Concentration, Power Failure, High Temperature, Low/No Flow), documented AC 230V ±10% (207–253 V) tolerance, and an on-panel running-hour display. Nuvo 10 publishes Loss of Power, System Malfunction, and No Flow on the local datasheet, and no user-visible hour counter on the same sheet.

Sub-2 L/min flow. HM-KX covers 0.5 L/min as its flow floor. Nuvo 10 floors at 2 L/min. For a titration regime dipping below 2 L/min (paediatric high-flow weaning, post-acute recovery tapering), HM-KX is the only one that delivers the prescribed flow continuously.

Where the Nidek Nuvo 10 wins

Clinical-trust premium and prescription-channel pull. Nidek is a recognised name among Indian pulmonologists, respiratory therapists, and hospital biomedical-equipment teams — a prescription-channel default for the 10 LPM class for over a decade. Where the pulmonologist or hospital discharge team specifies the unit, Nuvo is more likely to be the named brand. Real ecosystem advantage, not marketing.

FDA + CE paperwork. Nidek carries US FDA approval and CE certification. HM-KX carries CDSCO (the Indian regulatory gate) plus ISO 9001 and ISO 13485. For procurement requiring FDA listing — some hospital empanelments, corporate tenders, international deployments — Nuvo clears the checkbox HM-KX does not.

Outlet pressure. Nuvo 10’s 15 psi against HM-KX’s 0.04–0.06 MPa (~5.8–8.7 psi) is a real advantage for long tubing runs, humidifier-bottle setups with back-pressure, and certain ventilator-bridging configurations.

Secondary-market resale. Nidek’s installed base produces the strongest resale retention among 10 LPM imports in India. HM-KX’s secondary market is thinner because the installed base is smaller and newer. For short-term or transitional use (post-surgical recovery, bridging to transplant), Nuvo’s resale closes part of the upfront price gap.

Broader urban service network. Nidek’s authorised-channel coverage in metros and tier-1 cities is deeper and older than HM-KX’s. For a warranty claim in Delhi NCR, Mumbai, Bengaluru, Chennai, Hyderabad, Pune, or Kolkata, Nuvo’s service reach is the lower-downtime pick. HM-KX service is credible in South and West India but thinner elsewhere.

Compressor-longevity track record. Nidek’s Nuvo compressor has decades of deployed field data across global LTOT use. HM-KX’s 10,000-hour warranty is competitive on paper, but the installed-field data on duty-cycle life is shorter.

Indian-market considerations

• Stabiliser sizing. HM-KX at 550 VA → 825 VA servo stabiliser. Nuvo 10 at 600 W → 900 VA. For areas with frequent outages, pair either unit with an online UPS or a pure-sine inverter — never a square-wave inverter, which damages the compressor motor.
• Electricity cost. 24/7 HM-KX at ₹8/kWh is ~₹3,200/month; Nuvo 10 ~₹3,500/month — ~8–9% lower for HM-KX. Over 36 months, ~₹10,800 lower operating cost for HM-KX on the same duty.
• Altitude derating. Both see 2–4% purity drop above 2,000 m. Nuvo 10 publishes 5,000 ft (~1,525 m) operating altitude; HM-KX does not publish one. For Shimla, Manali, Gangtok, Darjeeling, and Ooty residents, flag for both.
• GST, CGHS, ECHS. 12% GST applies to both. Qualifying buyers can route through CGHS, ECHS, ESIC, or private-insurance home-medical-equipment reimbursement with a GST-invoiced purchase and a standing oxygen prescription.
• Service reach. In metro cities and the South/West corridor, both units are serviceable. Outside that corridor, ask both dealers for specific warranty-claim turnaround, spare-parts stocking (sieve beds, compressors, filter sets), and bridge-rental availability. Treat soft answers as a red flag for either brand.

Who should pick which

Pick the Nidek Nuvo 10 if the prescribing pulmonologist has named it, if the procurement process requires FDA-listed paperwork, if clinical-trust premium is load-bearing for the household, if secondary-market resale matters (short-term or transitional use), if the setup involves long tubing runs where 15 psi outlet pressure is a real advantage, or if the buyer is in a North Indian metro where Nidek’s authorised-service reach is the lower-downtime pick.

Pick the Home Medix HM-KX 10 LPM if the buyer is a home LTOT patient in a Home-Medix-served city, if the ~₹60,000–₹80,000 price saving is meaningful to the budget, if the patient is also on regular nebulized medication and the integrated nebulizer removes the need for a second compressor, if the caregiver-presence dynamic makes the SOS siren genuinely useful, if a sub-2 L/min flow-floor is part of the prescription, or if the sound floor of ≤ 48 dB(A) field-verified and the lowest-in-class 550 VA draw are first-order purchase axes.

Verdict

Context-dependent tie on the merits. Sound floor is a tie-or-HM-KX-win depending on which Nuvo 10 published figure you anchor to. Power narrowly favours HM-KX. Price heavily favours HM-KX. Integrated nebulization, SOS siren, full alarm suite, user-visible hour counter, and documented AC ±10% tolerance are HM-KX-only. FDA + CE paperwork, clinical-trust reputation, outlet pressure, resale retention, and broader urban service reach favour Nuvo. Pick on use-case, not on aggregate ranking.

Before committing to any 10 LPM unit, confirm the prescription genuinely requires >5 L/min — many patients are over-specced and a 5 LPM unit covers the need at ~40% less. Consult the prescribing pulmonologist on the actual flow trajectory before the purchase.